Assetmark, Inc Becton Dickinson & CO Transaction History

Assetmark, Inc

$32.1 Billion
Q2 2024

A detailed history of Assetmark, Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Assetmark, Inc holds 31,684 shares of BDX stock, worth $7.65 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

31,684

Previous 30,986 2.25%

Holding current value

$7.65 Million

Previous $7.67 Million 3.43%

% of portfolio

0.02%

Previous 0.03%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$225.07 - $246.17 $157,098 - $171,826	698 Added 2.25%	31,684 $7.4 Million
Q1 2024 May 06, 2024	BUY	$233.45 - $247.73 $344,338 - $365,401	1,475 Added 5.0%	30,986 $7.67 Million
Q4 2023 Feb 09, 2024	BUY	$232.24 - $267.23 $301,215 - $346,597	1,297 Added 4.6%	29,511 $7.2 Million
Q3 2023 Oct 27, 2023	BUY	$254.9 - $283.59 $1.1 Million - $1.22 Million	4,315 Added 18.06%	28,214 $7.29 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $724,228 - $806,042	3,038 Added 14.56%	23,899 $6.31 Million
Q1 2023 May 05, 2023	BUY	$229.71 - $259.35 $571,977 - $645,781	2,490 Added 13.55%	20,861 $5.16 Million
Q4 2022 Feb 10, 2023	BUY	$218.29 - $256.91 $884,074 - $1.04 Million	4,050 Added 28.28%	18,371 $4.67 Million
Q3 2022 Nov 01, 2022	BUY	$51.03 - $264.23 $152,630 - $790,311	2,991 Added 26.4%	14,321 $3.19 Million
Q2 2022 Aug 03, 2022	BUY	$234.74 - $275.42 $1.31 Million - $1.54 Million	5,596 Added 97.59%	11,330 $2.79 Million
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $1.04 Million - $1.15 Million	4,262 Added 289.54%	5,734 $1.53 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $176,471 - $192,470	767 Added 108.79%	1,472 $370,000
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $7,447 - $8,207	32 Added 4.75%	705 $173,000
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $9,306 - $10,183	40 Added 6.32%	673 $164,000
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $126,721 - $140,256	-546 Reduced 46.31%	633 $154,000
Q4 2020 Feb 10, 2021	SELL	$221.92 - $245.94 $34,397 - $38,120	-155 Reduced 11.62%	1,179 $295,000
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $80,913 - $103,785	-375 Reduced 21.94%	1,334 $310,000
Q2 2020 Aug 11, 2020	BUY	$219.9 - $263.41 $71,027 - $85,081	323 Added 23.3%	1,709 $409,000
Q1 2020 May 12, 2020	SELL	$195.69 - $279.01 $1.18 Million - $1.68 Million	-6,012 Reduced 81.27%	1,386 $318,000
Q4 2019 Feb 11, 2020	BUY	$236.45 - $266.82 $65,969 - $74,442	279 Added 3.92%	7,398 $2.01 Million
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $1.56 Million - $1.73 Million	6,775 Added 1969.48%	7,119 $1.8 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $652 - $738	-3 Reduced 0.86%	344 $87,000
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $22,253 - $26,802	-108 Reduced 23.74%	347 $87,000
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $10,236 - $12,896	-50 Reduced 9.9%	455 $103,000
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $2,563 - $2,816	-11 Reduced 2.13%	505 $132,000
Q2 2018 Aug 01, 2018	SELL	$208.1 - $233.85 $11,029 - $12,394	-53 Reduced 9.31%	516 $124,000
Q1 2018 May 16, 2018	SELL	$205.46 - $240.27 $6.2 Million - $7.26 Million	-30,200 Reduced 98.15%	569 $123,000
Q4 2017 Feb 13, 2018	BUY	$189.0 - $222.64 $5.7 Million - $6.71 Million	30,153 Added 4894.97%	30,769 $6.59 Million
Q3 2017 Nov 08, 2017	BUY	$186.89 - $198.9 $7,101 - $7,558	38 Added 6.57%	616 $121,000
Q2 2017 Aug 15, 2017	SELL	N/A	-137 Reduced 19.16%	578 $113,000
Q1 2017 Sep 15, 2017	SELL	N/A	-32 Reduced 4.28%	715 $131,000
Q4 2016 Sep 15, 2017	BUY	N/A	6 Added 0.81%	747 $124,000
Q3 2016 Sep 15, 2017	BUY	N/A	184 Added 33.03%	741 $133,000
Q2 2016 Sep 15, 2017	SELL	N/A	-132 Reduced 19.16%	557 $94,000
Q1 2016 Sep 15, 2017	BUY	N/A	25 Added 3.77%	689 $105,000
Q4 2015 Sep 15, 2017	BUY	N/A	664	664 $102,000

Others Institutions Holding BDX

# of Institutions

1,733

Shares Held

252M

Call Options Held

586K

Put Options Held

649K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account